Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome

IMPORTANCE: Oral propranolol is widely considered to be first-line therapy for complicated infantile hemangioma, but its use in patients with PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome has been debated owing to concerns that the car...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Dermatol
Main Authors: Olsen, Gerilyn M., Hansen, Leanna M., Stefanko, Nicole S., Mathes, Erin, Puttgen, Katherine B., Tollefson, Megha M., Lauren, Christine, Mancini, Anthony J., McCuaig, Catherine C., Frieden, Ilona J., Adams, Denise, Baselga, Eulalia, Chamlin, Sarah, Gupta, Deepti, Frommelt, Peter, Garzon, Maria C., Horii, Kimberly, Klajn, Justyna, Maheshwari, Mohit, Newell, Brandon, Nguyen, Henry L., Nopper, Amy, Powell, Julie, Siegel, Dawn H., Drolet, Beth A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990697/
https://ncbi.nlm.nih.gov/pubmed/31825455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2019.3839
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados